Clinical Cancer Research Prevention Award Frontiers in Basic Cancer Research
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Karashima, T.
Right arrow Articles by Dinney, C. P. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Karashima, T.
Right arrow Articles by Dinney, C. P. N.
Clinical Cancer Research Vol. 9, 2786-2797, July 2003
© 2003 American Association for Cancer Research


Experimental Therapeutics, Preclinical Pharmacology

Nuclear Factor-{kappa}B Mediates Angiogenesis and Metastasis of Human Bladder Cancer through the Regulation of Interleukin-81

Takashi Karashima, Paul Sweeney, Ashish Kamat, Suyun Huang, Sun J. Kim, Menashe Bar-Eli, David J. McConkey and Colin P. N. Dinney2

Departments of Cancer Biology [T. K., S. H., S. J. K., M. B-E., D. J. M., C. P. N. D.] and Urology [P. S., A. K., C. P. N. D.], The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030

Purpose: Interleukin (IL)-8 is an important mediator of angiogenesis, tumorigenicity, and metastasis in transitional cell carcinoma (TCC) of the bladder. Nuclear factor {kappa}B (NF-{kappa}B)/relA regulates IL-8 expression in several neoplasms. The purpose of this study was to determine whether the organ microenvironment (hypoxia, acidosis) regulates the expression of IL-8 in TCC via NF-{kappa}B, and whether inhibition of NF-{kappa}B function by mutant I{kappa}B-{alpha} prevents induction of IL-8 expression.

Experimental Design: IL-8 mRNA expression and protein production by human TCC cell lines (UM-UC-14, HTB-9, RT-4, KU-7 and 253J B-V) were measured by Northern blot analysis and ELISA under acidic (pH 7.35–6.0) and hypoxic (1.0% O2) conditions. The involvement of NF-{kappa}B and activator protein 1 in the regulation of IL-8 production was evaluated by electrophoretic mobility shift assay. Furthermore, the tumorigenicity and metastatic potential of UM-UC-14 cells were determined after transfection with mutant I{kappa}B-{alpha}.

Results: We found that acidic and hypoxic conditions increased IL-8 mRNA expression and protein production by several, but not all, TCC cell lines evaluated. NF-{kappa}B, but not activator protein 1, was inducibly activated in UM-UC-14 under both acidic and hypoxic conditions, but not in UM-UC-14 mutant I{kappa}B-{alpha} transfectants. Tumor growth and lymph node metastasis were inhibited in UM-UC-14 mutant I{kappa}B-{alpha} transfectants compared with UM-UC-14 controls. This effect was associated with the inhibition of IL-8 production, cellular proliferation, and angiogenesis.

Conclusions: These results suggest that TCCs of the bladder have heterogenic responses to physicochemical changes in the microenvironment and identify NF-{kappa}B as a potential molecular target for therapy.




This article has been cited by other articles:


Home page
Anticancer ResHome page
S. HARGUINDEY, J. L. ARRANZ, M. L. WAHL, G. ORIVE, and S. J. RESHKIN
Proton Transport Inhibitors as Potentially Selective Anticancer Drugs
Anticancer Res, June 1, 2009; 29(6): 2127 - 2136.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
D. J.J. Waugh and C. Wilson
The Interleukin-8 Pathway in Cancer
Clin. Cancer Res., November 1, 2008; 14(21): 6735 - 6741.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
J. M. Phillips and J. I. Goodman
Identification of Genes that May Play Critical Roles in Phenobarbital (PB)-Induced Liver Tumorigenesis due to Altered DNA Methylation
Toxicol. Sci., July 1, 2008; 104(1): 86 - 99.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
W. M. Merritt, Y. G. Lin, W. A. Spannuth, M. S. Fletcher, A. A. Kamat, L. Y. Han, C. N. Landen, N. Jennings, K. De Geest, R. R. Langley, et al.
Effect of Interleukin-8 Gene Silencing With Liposome-Encapsulated Small Interfering RNA on Ovarian Cancer Cell Growth
J Natl Cancer Inst, March 5, 2008; 100(5): 359 - 372.
[Abstract] [Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
D. Zhang, X. Jin, F. Wang, S. Wang, C. Deng, Z. Gao, and C. Guo
Combined Prognostic Value of Both RelA and I{kappa}B-{alpha} Expression in Human Non Small Cell Lung Cancer
Ann. Surg. Oncol., December 1, 2007; 14(12): 3581 - 3592.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
C. F. MacManus, J. Pettigrew, A. Seaton, C. Wilson, P. J. Maxwell, S. Berlingeri, C. Purcell, M. McGurk, P. G. Johnston, and D. J.J. Waugh
Interleukin-8 Signaling Promotes Translational Regulation of Cyclin D in Androgen-Independent Prostate Cancer Cells
Mol. Cancer Res., July 1, 2007; 5(7): 737 - 748.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S.-W. Jang, Y. S. Kim, Y. R. Kim, H. J. Sung, and J. Ko
Regulation of Human LZIP Expression by NF-{kappa}B and Its Involvement in Monocyte Cell Migration Induced by Lkn-1
J. Biol. Chem., April 13, 2007; 282(15): 11092 - 11100.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
A. Papageorgiou, A. Kamat, W. F. Benedict, C. Dinney, and D. J. McConkey
Combination therapy with IFN-{alpha} plus bortezomib induces apoptosis and inhibits angiogenesis in human bladder cancer cells
Mol. Cancer Ther., December 1, 2006; 5(12): 3032 - 3041.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
S. J. Braeuer, C. Buneker, A. Mohr, and R. M. Zwacka
Constitutively Activated Nuclear Factor-{kappa}B, but not Induced NF-{kappa}B, Leads to TRAIL Resistance by Up-Regulation of X-Linked Inhibitor of Apoptosis Protein in Human Cancer Cells
Mol. Cancer Res., October 1, 2006; 4(10): 715 - 728.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
E. K. Rofstad, B. Mathiesen, K. Kindem, and K. Galappathi
Acidic Extracellular pH Promotes Experimental Metastasis of Human Melanoma Cells in Athymic Nude Mice.
Cancer Res., July 1, 2006; 66(13): 6699 - 6707.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
K. Inoue, T. Karashima, S. Fukata, A. Nomura, C. Kawada, A. Kurabayashi, M. Furihata, Y. Ohtsuki, and T. Shuin
Effect of Combination Therapy with a Novel Bisphosphonate, Minodronate (YM529), and Docetaxel on a Model of Bone Metastasis by Human Transitional Cell Carcinoma
Clin. Cancer Res., September 15, 2005; 11(18): 6669 - 6677.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
D. Leibovici, H. B. Grossman, C. P. Dinney, R. E. Millikan, S. Lerner, Y. Wang, J. Gu, Q. Dong, and X. Wu
Polymorphisms in Inflammation Genes and Bladder Cancer: From Initiation to Recurrence, Progression, and Survival
J. Clin. Oncol., August 20, 2005; 23(24): 5746 - 5756.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
M.-T. Lin, C.-Y. Zuon, C.-C. Chang, S.-T. Chen, C.-P. Chen, B.-R. Lin, M.-Y. Wang, Y.-M. Jeng, K.-J. Chang, P.-H. Lee, et al.
Cyr61 Induces Gastric Cancer Cell Motility/Invasion via Activation of the Integrin/Nuclear Factor-{kappa}B/Cyclooxygenase-2 Signaling Pathway
Clin. Cancer Res., August 15, 2005; 11(16): 5809 - 5820.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. Cicek, R. Fukuyama, D. R. Welch, N. Sizemore, and G. Casey
Breast Cancer Metastasis Suppressor 1 Inhibits Gene Expression by Targeting Nuclear Factor-{kappa}B Activity
Cancer Res., May 1, 2005; 65(9): 3586 - 3595.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. K. Manna and G. T. Ramesh
Interleukin-8 Induces Nuclear Transcription Factor-{kappa}B through a TRAF6-dependent Pathway
J. Biol. Chem., February 25, 2005; 280(8): 7010 - 7021.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C.-R. Yang, S.-L. Hsieh, F.-M. Ho, and W.-W. Lin
Decoy Receptor 3 Increases Monocyte Adhesion to Endothelial Cells via NF-{kappa}B-Dependent Up-Regulation of Intercellular Adhesion Molecule-1, VCAM-1, and IL-8 Expression
J. Immunol., February 1, 2005; 174(3): 1647 - 1656.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2003 by the American Association for Cancer Research.